Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: Implications for premenopausal breast cancer risk

Molecular Genetics and Metabolism

Volumn 72, Issue 2, 2001, Pages 144-154

  Jernström, Helena ^a,b   Chu, William ^a   Vesprini, Danny ^a   Tao, Yuzhen ^c   Majeed, Noreen ^c   Deal, Cheri ^d   Pollak, Michael ^c   Narod, Steven A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

AIB1; CYP3A4; Genotype; IGF binding protein 3; IGF1; Insulin like growth factor 1 (IGF I); Oral contraceptives

Indexed keywords

ORAL CONTRACEPTIVE AGENT; SOMATOMEDIN C;

ADOLESCENT; ADULT; ALLELISM; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; DNA DETERMINATION; ESTROGEN METABOLISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HIGH RISK POPULATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE;

EID: 0035715780     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2000.3130     Document Type: Article

References (50)

1. Ethnicity and variation in breast cancer incidence
2. Racial differences in breast carcinoma survival
3. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
4. Oral contraceptive use and breast cancer risk among African-American women
5. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54
6. Adolescent reproductive events and subsequent breast cancer risk
7. Insulin-like growth factors and their binding proteins: Biological actions
8. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
9. IGF physiology and cancer risk
10. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men
11. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
12. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
13. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable premenopausal breast cancer
14. Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives
15. Genetic and non-genetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in healthy premenopausal women
16. Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism
17. Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: The Rancho Bernardo study
18. Potential impact on breast cancer risk of circulating insulin-like growth factor I modifications induced by oral HRT in menopause
19. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women
20. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
21. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: Implications for genetic studies of bone mineral density
22. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
23. Conformation sensitive-gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes
24. Normal and aberrant growth
25. Serum concentrations of insulin, insulin-like growth factor-I and insulin-like growth factor binding proteins are different between white and African American girls
26. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: A longitudinal study
27. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels
28. Sex steroid regulation of growth hormone secretion and action
29. Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus
30. Editorial: Perplexing polymorphism: D(i)ps, Sn(i)ps, and trips
31. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction
32. Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides
33. 17beta-Estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures
34. Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450
35. Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: Prediction of drug-drug interactions with 17 alpha-ethynylestradiol
36. The human hepatic cytochromes P450 involved in drug metabolism
37. Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?
38. Response: Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
39. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
40. Modification of breast cancer risk in BRCA1 mutation carriers by AIB1 gene
41. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures
42. Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women
43. Bone mineral density and risk of breast cancer in older women: The study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group
44. Bone mass and the risk of breast cancer among postmenopausal women
45. Bone mineral density and risk of breast cancer: Differences by family history of breast cancer. Study of Osteoporotic Fractures Research Group
46. Alleles of the estrogen receptor alpha-gene and an estrogen receptor cotranscriptional activator gene, amplified in breast cancer-1 (AIB1), are associated with quantitative calcaneal ultrasound
47. Expression of sex steroid receptors and IGF-1 mRNA in breast tissue - Effects of hormonal treatment
48. Increased cell division as a cause of human cancer